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POEMS syndrome; a rare multi-systemic disorder that overlaps common conditions
leading to confirmation bias
Karla B. Almaraz MD, Mary Lacy MD
Department of Internal Medicine
The University of New Mexico

BACKGROUND
POEMS syndrome
• (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal
protein, Skin changes) is a rare disease involving different systems of
the body.
• The diagnosis requires both mandatory criteria; polyneuropathy plus
a monoclonal plasma cell disorder as well as one major criterion
(osteosclerotic bone lesions, Castleman’s disease or elevated VEGF
levels) and at least one of the minor criteria (organomegaly,
endocrinopathy, skin changes, or ascites)

POEMS MATCHING CRITERIA

MANDATORY CRITERIA
(both required)
• Polyneuropathy
• Monoclonal plasma cell
disorder

• The exact incidence its unknown given the complexity of its clinical
manifestations; it commonly presents in the 5th and 6th decade
Confirmation Bias
• Using information that supports
initial diagnosis while ignoring
other information that does not
support the initial diagnosis

DISCUSSION

MAJOR CRITERIA
(one required)

MINOR CRITERIA
(one required)

• Osteosclerotic bone lesions
• Castleman’s disease or
• Elevated VEGF

• Organomegaly (hepatomegaly,
splenomegaly or
lymphadenopathy)
• Endocrinopathology
• Skin changes
(hyperpigmentantion,
hemangioma, Sclerodermoid
changes, Raynaud
phenomenon)
• Extravascular volume overload
(ascites, pleural effusion, lower
extremity edema)
• Hematologic features
(polycythemia, thrombocytosis)
• CNS involvement (Papilledema)

OTHER SIGNS AND SYMPTOMS
• Renal (acute and chronic renal failure)
• Cardiovascular (arterial and venous
thrombosis, stroke)
• Pulmonary involvement (pulmonary
hypertension)
****

• 40 year-women with a past medical history of untreated
latent TB who presented to an outside hospital with
progressive edema, ascites and was subsequently found to
have diffuse lymphadenopathy with a benign biopsy,
Control monoclonal
5% Ethanolgammopathy and sclerotic bony lesions.
Peach arrow; sclerotic bone lesions.

• Ultimately she was also diagnosed with Scleroderma given
sclerodactyly, Raynaud’s and a +anti-Scl-70 Ab.
• Her monoclonal gammopathy revealed two small IgA
lambda M-spikes but a normal hemoglobin, renal function,
and kappa/lambda ratio. A review of her PET scan did not
showed increased metabolic activity in the sclerotic
lesions. Hematology/oncology felt this presentation was
most consistent with a monoclonal gammopathy of
undetermined significance (MGUS) associated with her
Scleroderma.
• Eventually she was treated with epoprostenol for severe
PAH. After initiation patient noted worsening of burning
sensation in hands and feet that she later endorsed
preceded initiation of the drug.
• A paracentesis revealed a serum-ascites albumin gradient
(SAAG) of 0.7 consistent with a non-portal hypertension
etiology and inconsistent with PAH being the sole etiology
of ascites. Analysis of ascitic fluid was negative for
malignancy or TB. A later paracentesis confirmed a low
SAAG.
• An elevated VEGF solidified the diagnosis

TAKE HOME POINTS
• This case highlights the tendency towards
confirmation bias in patients with a new diagnosis of a
rare disease, our patient’s signs and symptoms that
arose from Scleroderma and its treatment obscured
her presentation with POEMS syndrome.
• POEMS syndrome is a rare cause of low-SAAG
ascites
• Consider POEMS in any patient signs and symptoms
of polyneuropathy and monoclonal gammopathy

CASE/TIMELINE

• VZTransferred to our hospital for concern for pulmonary
hypertension (PAH) that was confirmed by right heart
catheterization.

• Our patient’s peripheral neuropathy was assumed to be a side
effect of PAH medication and it was not until later that it was
recognized that her symptoms predated epoprostenol.
• Her low-level monoclonal gammopathy was attributed to her
autoimmune disorder.
• Her low-SAAG ascites was inconsistent with portal hypertension,
but defining an alternative etiology for this was not initially
successful.
• In retrospect, our patient met mandatory, major and minor criteria
even before her VEGF returned elevated. Inconsistencies of
clinical manifestations with lab work should highlight the
possibility of confirmation bias and should alert the clinician to
consider alternative diagnoses.

REFERENCES

CONFIRMATION BIAS

Patient initially admitted for
decompensated right sided heart
failure due pulmonary HTN secondary
to Scleroderma with associated
ascites.

Medication side effect. Burning
sensation of extremities worsened
after induction of epoprostenol.

Monoclonal gammopathy of
undetermined significance (MGUS)
secondary to autoimmune disorder
(Scleroderma)

Ascites
Low SAAG

Polyneuropathy

Monoclonal
Gammopathy

Non-portal HTN; Low SAAG, but workup negative for active TB or
malignancy. Minor criteria for POEMS

Patient’s Polyneuropathy was
documented before the induction of
epoprostenol. Mandatory criteria for
POEMS

Normal kappa/lamda ratio, Hg and
renal function. Mandatory criteria for
POEMS

• Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions
and long-term outcome. Blood 2003; 101:2496 (Mayo clinic series).
• Cui RT, Yu SY, et al. The characteristics of ascites in patients with
POEMS syndrome. 10.1007/s00277-013-1829-7. Epub 2013 Jun 28.
• Ughi N, Ingegnoli F, Irace R, et al SAT0208 Prevalence of Monoclonal
Gammopathy of Undetermined Significance (MGUS) in Systemic
Sclerosis: Report from Two Italian Centers Annals of the Rheumatic
Diseases 2013;72:A651.

ACKNOWLEDGMENTS
- Thank you to the University of New Mexico Hospitals and medical staff
- In memory of those patients of whom we have learned medicine

